City of Hope, Novonco Therapeutics Inc. Announce First-In-Human Clinical Trial for COH29
Most of Morningstar's top Medalists are shining in a pack of broad returns.
Coach's fiscal first-quarter sales and earnings reflect an on-track brand relaunch; shares are still below fair value.
Amid global uncertainty, consumer cyclical companies with moats will fare the best, in our opinion.
Luggage maker Tumi travels toward moatworthy status in the luxury goods industry.
A possible bank default and soft industrial production figures have rekindled some nervousness about the European recovery.
The brand's quality and price should resonate with global consumers, particularly in Europe.
It's the wrong time to buy into these firms.
Steady U.S. retail spending and rebounding European and Chinese sales offer decent end-market outlooks for consumer cyclical companies, but the larger retail spending environment remains uncertain around the world.
The consumer shift to e-commerce is becoming more pronounced, but retailers are fighting back.